Update to Serious Shortage Protocols: Fluoxetine 40mg Capsules
The
Department of Health has released updated information (attached) on the Serious
Shortage Protocol (SSP) which was issued on 20 May 2020 in respect of
fluoxetine 40mg capsules.
Summary
The SSP was issued with an end date
of Monday 20 July 2020, which was extended until 4th September 2020.
The SSP has now been further extended until 25th September 2020.Details of the SSP are available on the BSO website and can be
accessed via this link: www.hscbusiness.hscni.net/services/3063.htm
Action
Contractors should:
Brief their dispensing teams
on the extension of the SSP.
CPNI colleagues will continue to support
contractors on these matters.
Kind regards
Mike
Sent
on behalf of Prof Mike Mawhinney | Head of Regulatory Affairs
Can I ask that you read this and share with your pharmacy staff
who are involved in preparing prescriptions for submission to BSO? We
appreciate the last number of months have been challenging in so many ways, but
need to remind you of the importance of having your prescriptions submitted to
BSO on time to ensure your pharmacy payment is not compromised.
Kind Regards,
SENT
FOR AND BEHALF OF GERARD GREENE | Chief Executive
Download
Dear
Colleague,
The
final update of concessionary prices for August 2020 have been released and are
as follows:
SENT
FOR AND BEHALF OF KATHERINE KIDD | Head of Pharmacy Development
Dear Colleague,
Further concessionary prices have been granted for August 2020:
Drug
Pack Size
Concessionary
Price
Alendronic
acid 10mg tablets
28
£5.75
Clonidine
25microgram tablets
112
£16.11
Entacapone
200mg tablets
30
£10.33
Erythromycin
250mg gastro-resistant tablets
28
£4.11
Esomeprazole
40mg gastro-resistant capsules
28
£4.59
Hydroxyzine
10mg tablets
84
£1.75
Moxonidine
300microgram tablets
28
£8.74
Nizatidine
150mg capsules
30
£7.47
Olanzapine
10mg tablets
28
£4.23
Prednisolone
20mg tablets
30
£7.19
Rasagiline
1mg tablets
28
£20.41
Tacrolimus
0.1% ointment
30
£24.95
Tacrolimus
0.1% ointment
60
£46.64
Valproic
acid 150mg gastro-resistant capsules
100
£11.37
Valproic
acid 300mg gastro-resistant capsules
100
£22.77
Valproic
acid 500mg gastro-resistant capsules
100
£30.00
Kind regards,
Katherine
SENT
FOR AND BEHALF OF KATHERINE KIDD | Head of Pharmacy Development
Dear
Colleague
Please
find attached for your attention, correspondence from Joe Brogan, Assistant
Director of Integrated Care, Head of Pharmacy and Medicines Management.
The
attached letter provides further details of the Community Pharmacy Home
Delivery Service which is being commissioned by HSCB from Tuesday 1st September 2020. The service will remain in
place until a date specified by HSCB. In the first instance it will run until
31st March 2021.
The
aim of this service is to ensure that eligible patients during the COVID-19
pandemic who do not have a family member, friend or carer or volunteer who can
collect and deliver their prescription medicines on their behalf, can have
their medicines delivered in a manner which keeps both them and pharmacy staff
safe from COVID-19.
In
line with DoH policy, patient eligibility is defined as those patients who are
deemed to be clinically extremely vulnerable should they become infected with
the COVID-19 virus. The full list of eligible patient groups is set out at
Annex A of the attached service specification.
ACTION
REQUIRED
I
would ask that you review the attached service specification, develop a
Standard Operating Procedure, and ensure that all relevant staff are
trained and competent to deliver this service.
The
attached Privacy Notice should be amended to suit your individual
pharmacy’s requirements and displayed.
If you have a query about this service, please contact your local HSCB Pharmacy Adviser or the CPNI office.
Yours sincerely
SENT FOR AND BEHALF
OF GERARD GREENE | Chief Executive
Download
Dear Colleague
Please find attached for your attention, correspondence from Joe
Brogan, Assistant Director of Integrated Care, Head of Pharmacy and Medicines
Management.
HSCB, DOH and CPNI have been working to establish which
pharmaceutical services may be safely reintroduced. It has been agreed that
community pharmacies may recommence the provision of the Minor Ailments Service
from Tuesday 1st September 2020.
The ongoing pandemic may, however, affect the ability of some
pharmacies to safely deliver this service in its current format. Therefore,
some flexibility in how pharmacies can deliver this service has been agreed and
is outlined in the attached letter.
ACTION REQUIRED
Pharmacies may find the checklist, in Appendix 1 of the
attached letter, useful to ensure that they are able to deliver this
service safely, minimising the risk to both patients and pharmacy teams of
contracting COVID-19.
Ensure that an updated Standard Operating Procedure
(SOP) is in place to support delivery of the service.
Ensure that all pharmacy staff involved in the delivery
of the service are fully competent and knowledgeable in all processes and
procedures relating to this service.
Ensure that the appropriate PV1s are used in the
delivery of this service. (Please reserve NCR duplicate copy PV1s for the
delivery of the Emergency Supply Service only).
Please inform your local HSCB Integrated Care Office by
11th September 2020 if your pharmacy will not be in a
position to recommence offering this service.
If you have any query about this service, please contact your
local HSCB Pharmacy Adviser or the CPNI Office.
Yours sincerely
SENT
FOR AND BEHALF OF GERARD GREENE | Chief Executive
Download
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
